Moteur de recherche d’entreprises européennes
Financement de l’UE (5 832 536 €) : Soins individualisés pour les personnes âgées atteintes de maladies chroniques complexes à domicile et dans les maisons de soins infirmiers Hor12/02/2021 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Soins individualisés pour les personnes âgées atteintes de maladies chroniques complexes à domicile et dans les maisons de soins infirmiers
BACKGROUND Optimal care for older patients with complex chronic conditions (CCC) is challenging. Not only do older patients with CCC present with multiple conditions and functional impairments, these often interact with each other, as well as with their treatments. Patients with CCC are concentrated in home care and nursing home settings. Professionals working in these settings often lack appropriate decision support that mirrors the medical and functional complexity of these persons. AIM To improve prognoses and estimation of treatment impact for older care recipients with CCC in home care and nursing homes settings, and develop, validate, and test next generation individualised decision support. IMPACT Better informed decision making for clinical management of older care recipients with CCC in home care and nursing homes, through (1) high quality internationally validated predictive algorithms on disease trajectories and treatment outcomes; (2) a multi-nationally tested e-platform for health professionals to receive predictive scenarios on course and treatment outcomes of newly assessed care recipients at point of care; and (3) dissemination among health professionals working in nursing homes and home care. APPROACH We collated longitudinal data from 52 million older recipients of home care and nursing home care from eight countries including (1) highly reliable, valid and harmonised comprehensive assessments of functional capacities, diseases, and treatments, linked with (2) administrative repositories on mortality and care use. We develop and validate decision support algorithms using a variety of techniques including machine learning to better predict (i) outcomes (eg death, acute admissions, quality of life) and the modifying impact of (ii) pharmacological and (iii) non-pharmacological treatments. We co-create decision support output with health professionals and patients and pilot it's applicability at point of care with an e-platform.
| European Union Geriatric Medicine Society Aisbl | 215 769 € |
| HEBREW REHABILITATION CENTER | 568 189 € |
| Istituto Superiore Di Sanita | 184 350 € |
| Karolinska Institutet | 307 823 € |
| Katholieke Universiteit Leuven | 503 435 € |
| NHG FINLAND Oy | 529 530 € |
| PROFILITY (ISRAEL) Ltd. | 444 719 € |
| STICHTING AMSTERDAM UMC | 999 155 € |
| STICHTING VU | 300 775 € |
| TERVEYDEN JA HYVINVOINNIN LAITOS | 339 270 € |
| Universita Cattolica Del Sacro Cuore | 661 134 € |
| University OF Waterloo | 0,00 € |
| Univerzita Karlova | 386 048 € |
| Uniwersytet Jagiellonski | 392 341 € |
https://cordis.europa.eu/project/id/965341
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "European Union Geriatric Medicine Society Aisbl - Financement de l’UE (5 832 536 €) : Soins individualisés pour les personnes âgées atteintes de maladies chroniques complexes à domicile et dans les maisons de soins infirmiers"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
